RECENT UPDATE ON PYRIMIDINE DERIVATIVES AS POTENTIAL DPP-IV INHIBITORS FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS. Journal of Pharmaceutical Negative Results, [S. l.], p. 5734–5743, 2022. DOI: 10.47750/pnr.2022.13.S07.696. Disponível em: https://www.pnrjournal.com/index.php/home/article/view/5581.. Acesso em: 11 jun. 2026.